These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8553869

  • 1. Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
    Lark MW, Bayne EK, Lohmander LS.
    Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869
    [No Abstract] [Full Text] [Related]

  • 2. Keratan sulfate in body fluids in joint disease.
    Thonar EJ, Masuda K, Häuselmann HJ, Uebelhart D, Lenz ME, Manicourt DH.
    Acta Orthop Scand Suppl; 1995 Oct; 266():103-6. PubMed ID: 8553836
    [No Abstract] [Full Text] [Related]

  • 3. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS.
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring.
    Sandy JD, Plaas AH, Koob TJ.
    Acta Orthop Scand Suppl; 1995 Oct; 266():26-32. PubMed ID: 8553857
    [No Abstract] [Full Text] [Related]

  • 8. Cartilage aggrecan. Biosynthesis, degradation and osteoarthritis.
    Neame PJ, Sandy JD.
    J Fla Med Assoc; 1994 Mar; 81(3):191-3. PubMed ID: 8195777
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
    Glant TT, Cs-Szabó G, Nagase H, Jacobs JJ, Mikecz K.
    Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ.
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [Abstract] [Full Text] [Related]

  • 14. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS, Ionescu M, Jugessur H, Poole AR.
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [Abstract] [Full Text] [Related]

  • 15. [Aggrecan].
    Watanabe H.
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():821-3. PubMed ID: 16149651
    [No Abstract] [Full Text] [Related]

  • 16. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.
    Poole AR, Ionescu M, Swan A, Dieppe PA.
    J Clin Invest; 1994 Jul; 94(1):25-33. PubMed ID: 7518830
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Mechanisms of degradation of argecanes in osteoarthritic cartilage].
    Lohmander LS, Lark MW, Sandy JD.
    Rev Prat; 1996 Mar 15; 46(6 Spec No):S11-S14. PubMed ID: 8731724
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.